Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,253,942
+$1,893,854 QoQ
Shares Held
276,623
-1.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#372
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. JNJ ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
37,816,285 | $267,739,296 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,910,947 | $245,556,688 | |
| 3 | PFE |
Pfizer Inc
|
7,634,806 | $183,846,126 | |
| 4 | SNY |
Sanofi
|
4,136,417 | $176,459,547 | |
| 5 | GSK |
GSK plc
|
1,483,198 | $77,749,239 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
276,623 | $70,253,942 | |
| 7 | NVS |
Novartis AG
|
197,593 | $30,966,774 | |
| 8 | OGN |
Organon & Co.
|
729,502 | $9,877,456 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,253,942 | 276,623 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $68,360,088 | 279,660 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $86,745,574 | 419,162 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $78,071,090 | 421,050 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $62,744,352 | 410,765 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $66,711,293 | 402,263 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $57,404,304 | 396,932 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $55,314,803 | 341,323 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,438,565 | 324,566 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $43,861,973 | 277,274 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $42,087,666 | 268,519 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $33,311,809 | 213,880 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $28,393,796 | 171,543 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,288,560 | 163,152 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $22,962,732 | 129,990 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $24,937,393 | 152,653 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,887,346 | 145,836 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $23,701,853 | 133,735 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $20,320,890 | 118,787 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $18,969,789 | 117,460 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,508,566 | 106,280 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $11,148,845 | 67,836 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,617,018 | 61,107 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $8,116,340 | 54,516 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,401,958 | 66,856 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $10,061,210 | 76,727 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||